|
1
|
NANETS consensus guidelines for the diagnosis of neuroendocrine tumor.
|
Pancreas
|
2010
|
1.90
|
|
2
|
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
|
Am J Clin Oncol
|
2008
|
1.84
|
|
3
|
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.
|
Pancreas
|
2010
|
1.51
|
|
4
|
Surgery in malignant pancreatic neuroendocrine tumors.
|
J Surg Oncol
|
2007
|
1.51
|
|
5
|
Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors.
|
J Surg Res
|
2010
|
1.47
|
|
6
|
Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature.
|
Dig Dis Sci
|
2010
|
1.25
|
|
7
|
Presentation, treatment, and outcome of type 1 gastric carcinoid tumors.
|
J Surg Oncol
|
2006
|
0.97
|
|
8
|
Clinical and prognostic features of rectal neuroendocrine tumors.
|
Neuroendocrinology
|
2013
|
0.96
|
|
9
|
The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix.
|
Am J Surg
|
2011
|
0.88
|
|
10
|
Early and late results of valvular surgery for carcinoid heart disease.
|
J Am Coll Cardiol
|
2008
|
0.86
|
|
11
|
Testicular metastasis of primary cecal carcinoid tumor.
|
Ann Diagn Pathol
|
2004
|
0.86
|
|
12
|
In vitro chemoresistance testing in well-differentiated carcinoid tumors.
|
Ann Surg Oncol
|
2009
|
0.85
|
|
13
|
Biochemical assessment of niacin deficiency among carcinoid cancer patients.
|
Am J Gastroenterol
|
2005
|
0.84
|
|
14
|
The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study.
|
Endocr Relat Cancer
|
2012
|
0.84
|
|
15
|
Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
|
J Clin Oncol
|
2013
|
0.84
|
|
16
|
Atypical lung carcinoid metastasis to breast: a case report.
|
Pancreas
|
2011
|
0.83
|
|
17
|
Serum pancreastatin: the next predictive neuroendocrine tumor marker.
|
J Surg Oncol
|
2013
|
0.82
|
|
18
|
Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors.
|
Pancreas
|
2011
|
0.82
|
|
19
|
Tubular carcinoid tumor: a rare cause of appendicitis.
|
Am Surg
|
2009
|
0.82
|
|
20
|
Management of goblet cell carcinoid.
|
J Surg Oncol
|
2006
|
0.82
|
|
21
|
Early bioprosthetic valve deterioration after carcinoid plaque deposition.
|
Ann Thorac Surg
|
2009
|
0.81
|
|
22
|
Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.
|
Neuroendocrinology
|
2015
|
0.79
|
|
23
|
Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor.
|
Pancreas
|
2014
|
0.79
|
|
24
|
Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.
|
Dig Dis Sci
|
2014
|
0.77
|
|
25
|
Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome.
|
J Vasc Interv Radiol
|
2008
|
0.77
|
|
26
|
The clinical utility of Ki-67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids.
|
J Surg Oncol
|
2010
|
0.77
|
|
27
|
Monoamine oxidase deficiency: a cause of symptomatic hyperserotoninemia in the absence of carcinoid.
|
Arch Intern Med
|
2002
|
0.75
|
|
28
|
Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.
|
Pancreas
|
2017
|
0.75
|
|
29
|
Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
|
Pancreas
|
2016
|
0.75
|
|
30
|
Primary pulmonary carcinoid tumor with metastasis to endometrial polyp.
|
Int J Surg Case Rep
|
2012
|
0.75
|
|
31
|
Composite glandular-endocrine tumor of the stomach in atrophic gastritis.
|
Am Surg
|
2010
|
0.75
|
|
32
|
Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors.
|
Pancreas
|
2016
|
0.75
|
|
33
|
Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors.
|
Pancreas
|
2017
|
0.75
|
|
34
|
Observations on the effects of lithium on carcinoid tumors.
|
Pancreas
|
2013
|
0.75
|
|
35
|
Laparoscopic antrectomy for retained antrum in type 1 gastric carcinoid: a case report and review of literature.
|
Pancreas
|
2013
|
0.75
|
|
36
|
Racial Disparities in Clinical Presentation and Surgical Outcomes in Patients with Small Bowel Carcinoid Tumors.
|
Am Surg
|
2016
|
0.75
|
|
37
|
Radioembolization-induced gastroduodenal ulcer.
|
Am Surg
|
2012
|
0.75
|
|
38
|
Use of Molecular Profiling to Guide Treatment Decisions in Patients with Neuroendocrine Tumors: Preliminary Results.
|
Am Surg
|
2016
|
0.75
|
|
39
|
The Prognostic Significance of Lymph Node Ratio in Carcinoid Tumors.
|
Pancreas
|
2016
|
0.75
|